May 27
Clinical Trials Funds Boost

Central West Cancer Service patients will benefit significantly from the recent fundraising efforts of two Canowindra residents.

Virginia Cullane and her daughter Jenny held a second-hand book stall during the week of the annual hot air balloon “Balloon Glow” event in Canowindra, selling over two tonnes of books and raising almost $13,000 for clinical trials in Orange.

Clinical trials Coordinator Alison Coote said their amazing efforts demonstrate the strong community support for the availability of clinical trials for cancer patients within our rural district.

“These funds provide a real boost for our clinical trials and will go toward the purchase of equipment, allowing us to offer a larger range of trials for our cancer patients,” she said.

Clinical trials aim to show whether a treatment is working, how it works, how it compares to current treatment and how best to use it.

Central West Cancer Service’s clinical trials are now available to patients at Orange in radiation oncology, medical oncology and haematology, providing them the opportunity to participate in trials much closer to home.

“All the medical research in the world does not mean a thing unless we are able to improve outcomes for our patients,” Ms Coote said.

She said the trials may be national or international studies, examining the latest treatments for cancer patients.

“Clinical trials examine new cancer treatments through patient-based research. They provide the critical data to determine whether potential new treatments are safe and effective.

“They are also essential for our doctors to learn more about oncology and how to improve the quality of life for cancer patients”.

Research shows that patients on clinical trials have better survival rates, simply for being on a clinical trial.

“We are very grateful to Virginia and Jenny Cullane for their commitment and efforts in raising funds to assist our clinical trials for our participating patients,” Ms Coote said. 

All clinical trials are required to include an informed consent process for patients that are considering taking partof it. This ensures participants are fully aware of the nature of the trial, the commitment required and any potential risks involved.